Clinical response to thalidomide in the treatment of intracranial tuberculomas: case report.

We describe a patient with multiple intracranial tuberculomas resistant to standard care with antituberculosis drugs and corticosteroids who responded well to thalidomide. Adjunctive thalidomide may have a role in the management of refractory intracranial tuberculomas, although it should be used conservatively owing to its potential adverse events.
AuthorsPatricia de la Riva, Miguel Urtasun, Tamara Castillo-Trivino, Xabier Camino, Maialen Arruti, Elisabet Mondragón, Adolfo Lopez de Munain
JournalClinical neuropharmacology (Clin Neuropharmacol) 2013 Mar-Apr Vol. 36 Issue 2 Pg. 70-2 ISSN: 1537-162X [Electronic] United States
PMID23503553 (Publication Type: Case Reports, Journal Article, Review)
Chemical References
  • Antitubercular Agents
  • Thalidomide
  • Adult
  • Antitubercular Agents (therapeutic use)
  • Clinical Trials as Topic (methods, trends)
  • Female
  • Humans
  • Thalidomide (therapeutic use)
  • Treatment Outcome
  • Tuberculoma, Intracranial (diagnosis, drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: